Texas Southern University at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Texas Southern University brings 5 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its work centres on nanoparticle and microparticle delivery for cancer, brain and lung targets, including paclitaxel particles aimed at M2 macrophages. Projects also test the stability and oral absorption of new agents against leishmaniasis and triple-negative breast cancer.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Texas Southern University Houston, TX | |
Poster Mon Oct 26 9:30am–10:30am The Effect of pH Stability and Aqueous Solubility on the Oral Bioavailability of a Novel Antileishmanial Agent Poster Mon Oct 26 10:30am–11:30am Novel 15-mer Anti-Triple Negative Breast Cancer Peptide: In Vitro Stability and Pharmacokinetics in Mice Poster Tue Oct 27 3:30pm–4:30pm Physicochemical Characterization of Inhalational Delivery System of Andrographolide-Loaded Mannose-Grafted Cyclodextrin Microparticles Using a Developed/Validated UPLC-PDA Method Poster Wed Oct 28 9:30am–10:30am Assessment of PLGA–Edaravone Nanoparticle Transport Across an Established Multicellular Blood–Brain Barrier Model Poster Wed Oct 28 11:30am–12:30pm Microfluidic Optimization of CD206+ M2 Macrophage-Targeted Paclitaxel PLGA-PEG Nanoparticles |
Instantly find 20 buyers from Texas Southern University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction